Tim Schlidt

If you can envision a solution that solves a customer’s problem, it helps to have technical skills if you want to bring it to market. But that’s not a requirement.

Hello friends and welcome to Daily Crunch, bringing you the most important startup, tech and venture capital news in a single package.

Previously relegated to underground communities and raves, ketamine, MDMA and psilocybin are now being studied to develop therapies to treat everything from PTSD to cluster headaches.